Israel Active

I reported previously about HyperQ from Israel’s Biological Signal Processing (BSP) that discovers heart problems that normal ECG tests cannot. BSP’s CEO Dr Yair Granot came on ILTV Daily and said HyperQ had been sold worldwide, including to anti-Israel Venezuela!

A new study in Austria has confirmed the anti-diabetic properties of the purslane herb extract Portulaca oleracea L. Israel’s Frutarom manufactures Portusana®, a scientifically supported and unique purslane extract.

Israel’s Moebius Medical is developing MM-II, a novel treatment for osteoarthritis pain. MM-II’s proprietary liposomes lubricate arthritic knee joints, to reduce friction and wear, and pain in the joints. Moebius has contracted with India's Sun Pharmaceutical to further develop MM-II.

Weizmann Institute scientists have discovered that some viruses (phages) secrete small molecules that are read and updated by other copies of the same virus.  Viruses use this to coordinate their attack and will go dormant if these molecules indicate that insufficient uninfected host cells remain.

I reported previously about Israel’s CoreBone which grows ultra-strong bone-graft material in the laboratory from corals.  CoreBone recently received both CE and ISO 13485 certification to allow the company to sell the product in Europe.

Israel’s Zebra Medical Vision has launched “Profound” –fast, accurate medical image analysis over the web.  Individuals can upload their medical imaging scans such as CTs and mammograms to Zebra’s online service, and receive an automated analysis for key clinical conditions. In addition, Zebra announced a new algorithm that can increase osteoporosis detection by 50%.

Israel’s Mininvasive makes the OmniCuff device that enables minimally invasive arthroscopic shoulder rotator cuff repair – with over 1 million potential operations annually.  Mininvasive has just announced a strategic partnership with China’s MicroPort Scientific Corporation.

I reported previously on Israel’s VBL Therapeutics (aka Vascular Biogenics) and its treatment VB-111 for brain cancer. VB-111 targets new blood vessels developed to feed the tumor. Also, delivering the treatment inside a virus triggers the immune system to attack the tumor.

Cadets in the IDF Technological Officers Training Course have developed a digital bracelet that medics attach to soldiers injured on the battlefield. Sensors monitor pulse, blood pressure, and body temperature. A chip tracks medication and procedures for handover to the hospital.

I reported previously on DermaCompare from Israel’s Emerald Medical Applications.  Founder Lior Wayn has just gone on ILTV to explain his app that uses any smartphone camera, imaging software and proprietary algorithms to identify skin moles that may develop into cancer.